Alzheimer's disease testing needs evidence, ethics, and equity The Lancet Neurology (++... ++)

Alzheimer's disease testing needs evidence, ethics, and equity The Lancet Neurology https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00324-8/fulltext?dgcid=raven_jbs_etoc_email Oct 2026 Volume 25Number 10p873-964, e14 https://www.thelancet.com/journals/laneur/issue/vol25no10/PIIS1474-4422(26)X2008-7 Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change Prof Jonathan Graff-Radford, MDa Send email to graff-radford.jonathan@mayo.edu ∙ Prof Leah Karliner, MD MASc ∙ Prof Deborah E Barnes, PhD MPHd ∙ Prof Giovanni B Frisoni, MDe ∙ Prof Reisa Sperling, MDf ∙ Nicolas Villain, MD PhDg,h ∙ et al. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00248-6/fulltext?dgcid=raven_jbs_etoc_feature_laneur Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Prof Merit E Cudkowicz, MDa Send email to cudkowicz.merit@mgh.harvard.edu ∙ Prof Jeremy Shefner, MDb ∙ Prof Leonard H van den Berg, MDc ∙ Prof Adriano Chio, MDd,e ∙ Prof Dongsheng Fan, MDf ∙ Prof Julian Großkreutz, MDg,h ∙ et al. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00277-2/fulltext?dgcid=raven_jbs_etoc_feature_laneur Maintenance Warning: TheLancet.com will undergo planned maintenance on Monday, 14th September, from approximately 04:30 to 17:30 BST. During this time, some site functionality will be temporarily unavailable. We apologise for any inconvenience.